ARGX Latest News, Press Relases and Analysis

All

Press Releases

16 days ago - By: Chartmill

ARGENX SE (NASDAQ:ARGX) Combines Minervini Trend Strength with Explosive Fundamental Growth

2 days ago - By: argenx SE

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease

2 days ago - By: argenx SE

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease

a month ago - By: Benzinga - Mentions: ARWR HSIC HUM LLY ...

10 Health Care Stocks With Whale Alerts In Today's Session

a month ago - By: Benzinga

$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today

a month ago - By: argenx SE

argenx Announces Results of Extraordinary General Meeting of Shareholders

a month ago - By: argenx SE

argenx Announces Results of Extraordinary General Meeting of Shareholders

a month ago - By: Zacks Investment Research - Mentions: KROS

KROS vs. ARGX: Which Stock Is the Better Value Option?

a month ago - By: Zacks Investment Research - Mentions: JNJ HALO

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View

2 months ago - By: Investor's Business Daily - Mentions: INSM UTHR LQDA

Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports

2 months ago - By: argenx SE

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: argenx SE

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: argenx SE

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

2 months ago - By: argenx SE

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

2 months ago - By: argenx SE

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

2 months ago - By: argenx SE

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

2 months ago - By: The Motley Fool - Mentions: TTD AMZN PEP CELH ...

Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks

2 months ago - By: argenx SE

argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session

2 months ago - By: argenx SE

argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session

2 months ago - By: argenx SE

argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025

2 months ago - By: argenx SE

argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025

3 months ago - By: Zacks Investment Research - Mentions: INCY

INCY vs. ARGX: Which Stock Is the Better Value Option?

3 months ago - By: Zacks Investment Research - Mentions: HALO ABBV ANIP

AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease

3 months ago - By: Investor's Business Daily - Mentions: XPH PPH XBI IBB ...

Pharma Tariffs Back In Spotlight On New Trump Threat

3 months ago - By: Investor's Business Daily - Mentions: UTHR AUPH HALO

ARGENX SE - ADR (ARGX) Stock News

ARGX Latest News, Press Relases and Analysis

ARGENX SE (NASDAQ:ARGX) Combines Minervini Trend Strength with Explosive Fundamental Growth

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease

10 Health Care Stocks With Whale Alerts In Today's Session

$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today

argenx Announces Results of Extraordinary General Meeting of Shareholders

argenx Announces Results of Extraordinary General Meeting of Shareholders

KROS vs. ARGX: Which Stock Is the Better Value Option?

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View

Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks

argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session

argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session

argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025

argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025

INCY vs. ARGX: Which Stock Is the Better Value Option?

AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease

Pharma Tariffs Back In Spotlight On New Trump Threat

United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results